ESTRADOT 37.5-0.585MG X 8 PATCHES [HORMONE THERAPY]
SKU PH108
$150.00
In stock — dispatches within 24h, tracked
Estradot 37.5 is an estradiol hormone replacement patch used to support healthy estrogen levels and relieve common menopausal symptoms such as hot flashes and night sweats. Each patch contains 0.585mg of estradiol and delivers approximately 37.5mcg per 24 hours.
Format8 Patches
Concentration0.585mg / Patch
Pay with Interac e-Transfer or Crypto
Ships from within Canada; No Customs
Discreet plain packaging; always
24h dispatch; Tracked Delivery
Estradot 37.5 is a transdermal hormone replacement therapy (HRT) containing estradiol 17β, the primary form of estrogen naturally produced by the ovaries before menopause. The patch provides a controlled release of estradiol through the skin and into the bloodstream, helping supplement declining estrogen levels associated with natural or surgically induced menopause.
Each Estradot 37.5 patch measures approximately 3.75cm² and contains 0.585mg of estradiol as estradiol hemihydrate. Importantly, the 0.585mg figure represents the total estradiol contained within the patch; the system is designed to release approximately 37.5 micrograms of estradiol every 24 hours. This pack contains 8 individually packaged transdermal patches.
Estradiol works by binding to estrogen receptors throughout the body and replacing some of the estrogen no longer produced in sufficient quantities after menopause. Restoring estrogen activity can help reduce vasomotor symptoms associated with estrogen deficiency, including hot flashes and sweating, while also influencing tissues such as the reproductive tract and bone. Estradot is approved in Canada for the relief of menopausal and postmenopausal symptoms and may also be used in appropriate patients for the prevention of osteoporosis associated with estrogen deficiency.
The transdermal delivery system continually releases small, controlled quantities of estradiol through the skin. Estradot patches are generally designed for twice weekly application, with each patch worn continuously for approximately three to four days, although the prescribed regimen should always be followed.
Estradot is an estrogen only product. In patients who still have a uterus, prolonged estrogen exposure can stimulate the endometrium, and a healthcare professional may determine that a progestogen should also be used to reduce the risk of endometrial hyperplasia. Hormone replacement therapy also carries important contraindications and potential risks, including certain estrogen sensitive cancers, blood clots, cardiovascular events and other conditions, making medical supervision important.
Estradot 37.5 is a prescription medication in Canada and should be used according to the directions provided by a qualified healthcare professional
Estradot 37.5 is a transdermal hormone replacement therapy patch containing estradiol 17β, the same principal estrogen produced naturally by the ovaries before menopause. Each patch contains 0.585mg of estradiol and is designed to release approximately 37.5mcg of estradiol per day through the skin and into the bloodstream. Each package contains 8 individually sealed patches.
Estradot is a prescription estrogen replacement therapy used for the relief of menopausal and postmenopausal symptoms associated with estrogen deficiency. It is also indicated in Canada for prevention of osteoporosis associated with naturally occurring or surgically induced estrogen deficiency when treatment is appropriate. Hormone replacement therapy should be individualized by a healthcare professional based on the patient's symptoms, medical history, and risk factors.
Estradot uses a transdermal matrix system that continuously releases controlled amounts of estradiol through the skin. The Estradot 37.5 patch provides a nominal estradiol delivery rate of approximately 37.5mcg per 24 hours. By delivering estradiol transdermally, the patch provides systemic estrogen exposure without requiring an oral tablet.
Estradot is used as continuous therapy and the patch is normally changed twice weekly, with each patch worn continuously for approximately 3 to 4 days. Application sites should be rotated, and the patch should be applied whole to clean, dry, intact skin according to the prescribing instructions. Estradot should not be applied to the breasts.
Estradot patches should be stored between 2°C and 30°C and must not be frozen. Each patch should remain inside its original protective pouch until it is ready to be applied. Patches should be kept out of the reach and sight of children and pets, including after use.
![ESTRADOT 37.5-0.585MG X 8 PATCHES [HORMONE THERAPY]](https://www.canadasteroiddepot.is/wp-content/uploads/2026/07/ESTRADAT-600x600.webp)
![ELLEACNELLE CYPROTERONE ACETATE 2000MCG / ETHINYLESTRADIOL 35MCG X 4 PACK [BIRTH CONTROL]](https://www.canadasteroiddepot.is/wp-content/uploads/2024/11/ab18b1b8-a99f-4cdc-80ad-9dbd9298fa6c-300x200.webp)
![ESTRADOT 37.5-0.585MG X 8 PATCHES [HORMONE THERAPY]](https://www.canadasteroiddepot.is/wp-content/uploads/2026/07/ESTRADAT-100x100.webp)